Drug Profile
NN 7128
Alternative Names: GlycoPEGylated Factor VIIa - Novo Nordisk; LA-rFVIIa - Novo Nordisk; N7-GP; NN7128; NNC 0128-0000-2011; NNC 0128-0000-2021; rFVIIa long-acting analogue - Novo NordiskLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Novo Nordisk
- Class Blood coagulation factors; Recombinant proteins; Serine endopeptidases
- Mechanism of Action Factor VIIa stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Haemophilia